JPRN-UMIN000030883
Not yet recruiting
Phase 1
Photodynamic Therapy (PDT) for malignant brain tumor in children. - Photodynamic Therapy (PDT) for malignant brain tumor in children.
Tokyo Women's Medical University0 sites20 target enrollmentStarted: January 28, 2018Last updated:
Overview
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- Tokyo Women's Medical University
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 6years-old to 20years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients without surgical tumor removal. 2\. Unusable for Talaporfin Sodium. 3\. Non intended histopathological types of brain tumor. 4\. Patients necessary for VEP monitoring. 5\. Pregnancy or possibility of pregnancy. 6\. Patients who are expected poor compliance with light shielding protection. 7\. Patients regarded as ineligible by principal investigator.
Investigators
Similar Trials
Completed
Phase 1
Photodynamic Therapy (PDT) for malignant brain tumor in children.Malignant brain tumor in childrenJPRN-jRCTs031180360kawamata takakazu5
Terminated
Phase 2
Photodynamic Therapy (PDT) For Recurrent High Grade GliomasBrain Tumor, RecurrentNCT01966809Harry T Whelan, MD1
Unknown
Phase 1
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsBrain and Central Nervous System TumorsMetastatic CancerNCT00002647Medical College of Wisconsin24
Active, not recruiting
Not Applicable
Photodynamic therapy as palliative treatment for recurrent squamous cell carcinom of the head and neck regioRecurrent squamous cell carcinoma of the head and neck RegionEUCTR2004-004452-39-DKChristel B. Lajer, Dep. of Otolaryngology head and neck surgery, Rigshospitalet50
Completed
Phase 1
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung CancerLung CancerNCT00025571Roswell Park Cancer Institute